Priscilla Zhang
Clinical Research Coordinator
Medicine
School of Medicine

Publications (4)

Top publication keywords:
NeoplasmsReceptor, ErbB-2Protein Kinase InhibitorsReceptor Protein-Tyrosine KinasesSignal TransductionErbB ReceptorsMicroRNAsReceptor, ErbB-3Proto-Oncogene ProteinsHead and Neck NeoplasmsTriazolesDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticBenzocycloheptenesQuinazolines

• Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
  Molecular cancer therapeutics 2013 Giles KM, Kalinowski FC, Candy PA, Epis MR, Zhang PM, Redfern AD, Stuart LM, Goodall GJ, Leedman PJ
• MicroRNA regulation of growth factor receptor signaling in human cancer cells.
  Methods in molecular biology (Clifton, N.J.) 2011 Giles KM, Barker A, Zhang PM, Epis MR, Leedman PJ
• Regulation of ErbB receptor signalling in cancer cells by microRNA.
  Current opinion in pharmacology 2010 Barker A, Giles KM, Epis MR, Zhang PM, Kalinowski F, Leedman PJ
• Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7.
  The Journal of biological chemistry 2008 Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ